The anti-double-stranded DNA (dsDNA) antibody test is a specialized diagnostic tool used in the diagnosis and monitoring of autoimmune diseases, particularly systemic lupus erythematosus (SLE). This test detects antibodies produced against double-stranded DNA (dsDNA), which is normally found in the nuclei of cells. The presence of these antibodies is specifically associated with lupus activity, and elevated levels often indicate disease flare-ups or organ involvement, such as kidney inflammation (lupus nephritis). Although a positive dsDNA test alone is not sufficient to definitively diagnose lupus, it holds high diagnostic value when combined with clinical symptoms (such as skin rash, joint inflammation, or kidney dysfunction) and other tests (such as ANA). Moreover, periodic monitoring of dsDNA antibody levels helps assess treatment response and predict disease relapses. This test is typically performed using ELISA or immunofluorescence methods and is considered a key tool in rheumatology for the targeted management of lupus patients.